BIRC5 and glioblastoma: Branched multipeptides from ERBB2, BIRC5, and CD99 stably bound with T2 cells, and multipeptide-pulsed denditric cells–cytotoxic T lymphocytes exhibited remarkable cytotoxic activity against primary glioblastoma cells.